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Introduction
Diffuse sclerosing osteomyelitis of the manidble ( DSMO)
is a form of chronic non-bacterial osteitis (CNO) and
predominantly affects patients < 18 years. It can result in
cosmetic disfigurement. No uniformly effective treatment
exists. Intravenous pamidronate (IV-PAM) has been
reported to be effective in multifocal CNO.
Objectives
To describe clinical and radiologic outcome of a DSMO
patient following treatment with IV-PAM.
Methods
A 4-year old Caucasian female was diagnosed with
DSMO and prospectively followed from 2007-2014. She
presented with a 20-month history of facial asymmetry
and painful bony expansion of the left hemimandible.
CT-scan revealed bone expansion suggestive of fibrous
dysplasia, but two consecutive bone biopsies revealed
inflammatory cells only. Infectious osteomyeltis was also
suspected, but cultures were negative and IV and oral
antibiotics were of no benefit. Focal MRI revealed bone
marrow and soft tissue edema with periosteal reaction,
consistent with DSMO. Subsequent whole-body MRI
revealed no other bony lesions. Naproxen was of no
benefit and she was started on monthly 1-day IV-PAM
infusions (1st dose 0.5mg/kg; each subsequent dose:
1mg/kg). The response to treatment was assessed
according to visual analogue score for pain ( VAS, 0=no
pain; 10=maximum pain), sequential MRIs and clinical
photos.
Results
She received 8 monthly IV-PAM infusions. After 1st dose,
VAS decreased from 10 to 0. MRI documented resolution
of abnormal signal at 5 months with gradual mandibular
remodelling. Clinical photos confirmed resolution of facial
asymmeter over 5 years with sustained improvement
at 7 years. She had a minor MRI confirmed flare at
67 months which responded to Naproxen monotherapy.
She remains asymptomatic at 84 month follow-up.
Conclusion
DSMO is challenging to diagnose and treat due to its
rareness and lack of uniformly effective treatment. IV-
PAM was effective in this young refractory patient and
resulted in resolution of pain, mandibular remodelling
and cosmetic improvement.
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